标题
Malignant transformation in non-functioning pituitary adenomas (pituitary carcinoma)
作者
关键词
Pituitary carcinomas, Non-functioning pituitary adenomas, Aggressive pituitary tumours, Metastases, Temozolomide
出版物
Pituitary
Volume 21, Issue 2, Pages 217-229
出版商
Springer Nature
发表日期
2018-01-03
DOI
10.1007/s11102-017-0857-z
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Temozolomide treatment can improve overall survival in aggressive pituitary tumors and pituitary carcinomas
- (2017) Hélène Lasolle et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- European Society of Endocrinology Clinical Practice Guidelines for the management of aggressive pituitary tumours and carcinomas
- (2017) Gerald Raverot et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Estrogen Receptor α, a Sex-Dependent Predictor of Aggressiveness in Nonfunctioning Pituitary Adenomas: SSTR and Sex Hormone Receptor Distribution in NFPA
- (2017) Kristin Astrid Øystese et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Aggressive Behavior in Silent Subtype III Pituitary Adenomas May Depend on Suppression of Local Immune Response: A Whole Transcriptome Analysis
- (2017) Timothy E. Richardson et al. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
- Role of tyrosine kinase inhibitors in the treatment of pituitary tumours
- (2017) Anat Ben-Shlomo et al. Current Opinion in Endocrinology Diabetes and Obesity
- O-6-Methylguanine-DNA methyltransferase expression is associated with pituitary adenoma tumor recurrence: a systematic meta-analysis
- (2017) Congxin Dai et al. Oncotarget
- Aggressive Pituitary Adenomas: The Dark Side of the Moon
- (2017) Stefano M. Priola et al. World Neurosurgery
- Growth hormone–secreting macroadenoma of the pituitary gland successfully treated with the radiolabeled somatostatin analog 90Y-DOTATATE: case report
- (2016) Joanna Waligórska-Stachura et al. JOURNAL OF NEUROSURGERY
- Genetic aspects of pituitary carcinoma
- (2016) Zijiang Yang et al. MEDICINE
- Silent subtype 3 pituitary adenomas are not always silent and represent poorly differentiated monomorphous plurihormonal Pit-1 lineage adenomas
- (2016) Ozgur Mete et al. MODERN PATHOLOGY
- Atypical pituitary adenomas: clinical characteristics and role of ki-67 and p53 in prognostic and therapeutic evaluation. A series of 50 patients
- (2016) Marialaura Del Basso De Caro et al. NEUROSURGICAL REVIEW
- Paradoxical and atypical responses to pasireotide in aggressive ACTH-secreting pituitary tumors
- (2016) Yona Greenman et al. Pituitary
- Radiotherapy with concurrent temozolomide for the management of extraneural metastases in pituitary carcinoma
- (2016) Carlos Kamiya-Matsuoka et al. Pituitary
- Increased expression of programmed death ligand 1 (PD-L1) in human pituitary tumors
- (2016) Yu Mei et al. Oncotarget
- Targeting PI3K/mTOR Signaling Displays Potent Antitumor Efficacy against Nonfunctioning Pituitary Adenomas
- (2015) M. Lee et al. CLINICAL CANCER RESEARCH
- Improvement in Diagnosis of Metastatic Pituitary Carcinoma by 68Ga DOTATATE PET/CT
- (2015) Jianqi Xiao et al. CLINICAL NUCLEAR MEDICINE
- The Complementary Role of Transcription Factors in the Accurate Diagnosis of Clinically Nonfunctioning Pituitary Adenomas
- (2015) Hiroshi Nishioka et al. ENDOCRINE PATHOLOGY
- Invasive, Atypical and Aggressive Pituitary Adenomas and Carcinomas
- (2015) Aydin Sav et al. ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA
- Long-Term Outcome and MGMT as a Predictive Marker in 24 Patients With Atypical Pituitary Adenomas and Pituitary Carcinomas Given Treatment With Temozolomide
- (2015) Daniel Bengtsson et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Temozolomide therapy in patients with aggressive pituitary adenomas or carcinomas
- (2015) Marco Losa et al. JOURNAL OF NEURO-ONCOLOGY
- Typical and Atypical Pituitary Adenomas: A Single-Center Analysis of Outcome and Prognosis
- (2015) Sabrina Chiloiro et al. NEUROENDOCRINOLOGY
- MicroRNA involvement in a metastatic non-functioning pituitary carcinoma
- (2015) Zhenqing Wei et al. Pituitary
- Histological criteria for atypical pituitary adenomas – data from the German pituitary adenoma registry suggests modifications
- (2015) Christian P. Miermeister et al. Acta Neuropathologica Communications
- Aggressive pituitary lesion with a remarkably high Ki-67
- (2014) Pedro Marques et al. Arquivos Brasileiros de Endocrinologia e Metabologia
- Letter to the Editor
- (2014) Kalman Kovacs et al. ENDOCRINE PATHOLOGY
- SSTR3 is a putative target for the medical treatment of gonadotroph adenomas of the pituitary
- (2014) Misu Lee et al. ENDOCRINE-RELATED CANCER
- Aggressive silent corticotroph adenoma progressing to pituitary carcinoma. The role of temozolomide therapy
- (2014) Olga Moshkin et al. Hormones-International Journal of Endocrinology and Metabolism
- Oncogene-induced senescence in pituitary adenomas and carcinomas
- (2014) Krystallenia Alexandraki et al. Hormones-International Journal of Endocrinology and Metabolism
- Somatostatin system: molecular mechanisms regulating anterior pituitary hormones
- (2014) T. Eigler et al. JOURNAL OF MOLECULAR ENDOCRINOLOGY
- Invasive adenoma and pituitary carcinoma: a SEER database analysis
- (2014) Tara M. Hansen et al. NEUROSURGICAL REVIEW
- Silent corticotroph adenomas
- (2014) Odelia Cooper Pituitary
- A new prognostic clinicopathological classification of pituitary adenomas: a multicentric case–control study of 410 patients with 8 years post-operative follow-up
- (2013) Jacqueline Trouillas et al. ACTA NEUROPATHOLOGICA
- Pituitary Carcinoma in Situ
- (2013) Francisco Pasquel et al. Endocrine Practice
- The Role of Temozolomide in the Treatment of a Patient with a Pure Silent Pituitary Somatotroph Carcinoma
- (2013) Leonardo Neto et al. Endocrine Practice
- DNA Mismatch Repair Protein (MSH6) Correlated With the Responses of Atypical Pituitary Adenomas and Pituitary Carcinomas to Temozolomide: The National Cooperative Study by the Japan Society for Hypothalamic and Pituitary Tumors
- (2013) Toshio Hirohata et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Treatment paradigms for pituitary adenomas: defining the roles of radiosurgery and radiation therapy
- (2013) Dale Ding et al. JOURNAL OF NEURO-ONCOLOGY
- High Response Rates and Prolonged Survival in Patients With Corticotroph Pituitary Tumors and Refractory Cushing Disease From Capecitabine and Temozolomide (CAPTEM)
- (2013) Brad E. Zacharia et al. NEUROSURGERY
- Peptide receptor radionuclide therapy in a patient with disabling non-functioning pituitary adenoma
- (2013) Jan Komor et al. Pituitary
- Peptide receptor radionuclide therapy for aggressive atypical pituitary adenoma/carcinoma: variable clinical response in preliminary evaluation
- (2013) Jillian Maclean et al. Pituitary
- Carcinoma of endocrine organs: Results of the RARECARE project
- (2012) Jan Maarten van der Zwan et al. EUROPEAN JOURNAL OF CANCER
- ACTH-secreting Crooke cell carcinoma of the pituitary
- (2012) Gábor L. Kovács et al. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
- Biomarkers of aggressive pituitary adenomas
- (2012) Ozgur Mete et al. JOURNAL OF MOLECULAR ENDOCRINOLOGY
- Silent or Subclinical Corticotroph Pituitary Macroadenoma Transforming Into Cushing Disease
- (2012) Eugen Melcescu et al. NEUROSURGERY
- First demonstration of the effectiveness of peptide receptor radionuclide therapy (PRRT) with 111In-DTPA-octreotide in a giant PRL-secreting pituitary adenoma resistant to conventional treatment
- (2012) S. Baldari et al. Pituitary
- On the robustness of mammalian circadian oscillators
- (2011) Charna Dibner CELL CYCLE
- Clinically silent somatotroph adenomas are common
- (2011) Alisha N Wade et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Pituitary Carcinoma with Malignant Growth from First Presentation and Fulminant Clinical Course—Case Report and Review of the Literature
- (2011) Katarzyna Dudziak et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Pituitary Carcinoma: Difficult Diagnosis and Treatment
- (2011) Anthony P. Heaney JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- A Mechanism of Acquiring Temozolomide Resistance During Transformation of Atypical Prolactinoma Into Prolactin-Producing Pituitary Carcinoma: Case Report
- (2011) Mineko Murakami et al. NEUROSURGERY
- Temozolomide responsiveness in aggressive corticotroph tumours: a case report and review of the literature
- (2011) A. K. Annamalai et al. Pituitary
- Anti-VEGF therapy in pituitary carcinoma
- (2011) Leon D. Ortiz et al. Pituitary
- The Somatostatin Analogue Octreotide Confers Sensitivity to Rapamycin Treatment on Pituitary Tumor Cells
- (2010) V. Cerovac et al. CANCER RESEARCH
- Temozolomide Treatment for Aggressive Pituitary Tumors: Correlation of Clinical Outcome with O6-Methylguanine Methyltransferase (MGMT) Promoter Methylation and Expression
- (2010) Zachary M. Bush et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Temozolomide Treatment in Aggressive Pituitary Tumors and Pituitary Carcinomas: A French Multicenter Experience
- (2010) Gérald Raverot et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- The epidemiology and genetics of pituitary adenomas
- (2009) Adrian F. Daly et al. BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM
- The pathophysiology of pituitary adenomas
- (2009) Dorota Dworakowska et al. BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM
- Prevalence of pituitary adenomas: a community-based, cross-sectional study in Banbury (Oxfordshire, UK)
- (2009) Alberto Fernandez et al. CLINICAL ENDOCRINOLOGY
- Mammalian target of rapamycin inhibitors rapamycin and RAD001 (everolimus) induce anti-proliferative effects in GH-secreting pituitary tumor cells in vitro
- (2009) Alexander Gorshtein et al. ENDOCRINE-RELATED CANCER
- Effect of Everolimus on Cell Viability in Nonfunctioning Pituitary Adenomas
- (2009) Maria Chiara Zatelli et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Silent subtype 3 carcinoma of the pituitary: a case report
- (2009) NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY
- In vitro and In vivo Radiosensitization Induced by the DNA Methylating Agent Temozolomide
- (2008) W. J. Kil et al. CLINICAL CANCER RESEARCH
- Silent subtype 3 pituitary adenoma: a clinicopathologic analysis of the Mayo Clinic experience
- (2008) D. Erickson et al. CLINICAL ENDOCRINOLOGY
- Role of Ki-67 proliferation index and p53 expression in predicting progression of pituitary adenomas
- (2008) Roger Gejman et al. HUMAN PATHOLOGY
- Modification of hormonal secretion in clinically silent pituitary adenomas
- (2008) Tania Daems et al. Pituitary
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started